Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial - Mismetti,P.; Mille,D.; Laporte,S. (Haematologica, 2003)